Pharmacokinetic and Pharmacodynamic Modelling

When to use

Use for concentration-time analysis, structural and population PK workflows, exposure-response, regimen simulation, bioequivalence planning, DDI screening, and research TDM calculations. Version 2.0 rejects unsupported replicate/scaled BE and oral/infusion closed-form summaries; model-target dose and lowest-HED output labels replace clinical recommendation labels. This skill computes exploratory quantities and documents assumptions; it does not establish clinical safety, recommend a patient dose, or certify a regulatory submission.

Fix the question and conventions first